Lancet Diabetes Endocrinol 13(6):482493 Stefanakis K, Kokkorakis M, Mantzoros CS (2024) The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation
It stresses that not all patients derive equal benefit, and pairs that with the caution that direct human trials of the pairing are limited
if you are cash-pay, the compounded comparison above is what matters
Tailored advice can prevent complications and maximize treatment benefits
But tirzepatide dosing is not a parameter that benefits from personalization
3 If you lose 10% to 15% of your body weight, your prescriber may reduce your levothyroxine to keep your TSH in range